Detalhe da pesquisa
1.
Methylthioadenosine Phosphorylase Genomic Loss in Advanced Gastrointestinal Cancers.
Oncologist
; 2024 Feb 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38330461
2.
Prevalence of targetable genomic alterations in young women with advanced breast cancer: a cross-sectional study.
Breast Cancer Res Treat
; 204(1): 181-185, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37999916
3.
Characterizing the Genomic Landscape of the Micropapillary Subtype of Urothelial Carcinoma of the Bladder Harboring Activating Extracellular Mutations of ERBB2.
Mod Pathol
; 37(3): 100424, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38219954
4.
Variable Landscape of PD-L1 Expression in Breast Carcinoma as Detected by the DAKO 22C3 Immunohistochemistry Assay.
Oncologist
; 28(4): 319-326, 2023 04 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36866462
5.
Comparative Genomic Landscape of Urothelial Carcinoma of the Bladder Among Patients of East and South Asian Genomic Ancestry.
Oncologist
; 28(10): e910-e920, 2023 10 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-37196060
6.
Mismatch repair deficiency, next-generation sequencing-based microsatellite instability, and tumor mutational burden as predictive biomarkers for immune checkpoint inhibitor effectiveness in frontline treatment of advanced stage endometrial cancer.
Int J Gynecol Cancer
; 33(4): 504-513, 2023 04 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36750267
7.
Advanced Squamous Cell Carcinomas of the Pelvic and Perineal Region: A Comprehensive Genomic Profiling Study.
Oncologist
; 27(12): 1016-1024, 2022 12 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35881043
8.
Molecular analysis of endometrial serous carcinoma reveals distinct clinicopathologic and genomic subgroups.
Gynecol Oncol
; 164(3): 558-565, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34998597
9.
Clinicopathologic, genomic and protein expression characterization of 356 ROS1 fusion driven solid tumors cases.
Int J Cancer
; 148(7): 1778-1788, 2021 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33336398
10.
Contrasting genomic profiles from metastatic sites, primary tumors, and liquid biopsies of advanced prostate cancer.
Cancer
; 127(24): 4557-4564, 2021 12 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34379803
11.
Comparative Genomic Analysis of Intrahepatic Cholangiocarcinoma: Biopsy Type, Ancestry, and Testing Patterns.
Oncologist
; 26(9): 787-796, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34080753
12.
Clinicopathologic and Genomic Landscape of Breast Carcinoma Brain Metastases.
Oncologist
; 26(10): 835-844, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34105210
13.
Clinicopathologic and genomic characterization of PD-L1-positive uterine cervical carcinoma.
Mod Pathol
; 34(7): 1425-1433, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33637877
14.
Clinicopathological and genomic characterization of BCORL1-driven high-grade endometrial stromal sarcomas.
Mod Pathol
; 34(12): 2200-2210, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34302054
15.
A pan-cancer analysis of PD-L1 immunohistochemistry and gene amplification, tumor mutation burden and microsatellite instability in 48,782 cases.
Mod Pathol
; 34(2): 252-263, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32884129
16.
Biomarkers in Breast Cancer: An Integrated Analysis of Comprehensive Genomic Profiling and PD-L1 Immunohistochemistry Biomarkers in 312 Patients with Breast Cancer.
Oncologist
; 25(11): 943-953, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32869930
17.
Clinical, histopathologic, and molecular profiles of PRKAR1A-inactivated melanocytic neoplasms.
J Am Acad Dermatol
; 84(4): 1069-1071, 2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-32682887
18.
Comprehensive Immunogenomic Profiling of IDH1-/2-Altered Cholangiocarcinoma.
JCO Precis Oncol
; 8: e2300544, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38547421
19.
Frequency and Nature of Genomic Alterations in ERBB2-Altered Urothelial Bladder Cancer.
Target Oncol
; 19(3): 447-458, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38570422
20.
Genomic landscape of clinically advanced KRAS wild-type pancreatic ductal adenocarcinoma.
Front Oncol
; 13: 1169586, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37404765